A detailed history of Capital Investment Counsel, LLC transactions in Merck & Co., Inc. stock. As of the latest transaction made, Capital Investment Counsel, LLC holds 54,650 shares of MRK stock, worth $5.55 Million. This represents 1.07% of its overall portfolio holdings.

Number of Shares
54,650
Previous 53,175 2.77%
Holding current value
$5.55 Million
Previous $6.58 Billion 5.73%
% of portfolio
1.07%
Previous 1.29%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

BUY
$111.15 - $128.97 $163,946 - $190,230
1,475 Added 2.77%
54,650 $6.21 Billion
Q2 2024

Aug 14, 2024

BUY
$123.8 - $132.96 $330,174 - $354,604
2,667 Added 5.28%
53,175 $6.58 Billion
Q1 2024

Aug 14, 2024

BUY
$113.24 - $131.95 $2.42 Million - $2.82 Million
21,347 Added 73.2%
50,508 $6.66 Billion
Q4 2023

Aug 14, 2024

BUY
$100.18 - $109.02 $2.92 Million - $3.18 Million
29,161 New
29,161 $3.18 Billion

Others Institutions Holding MRK

About Merck & Co., Inc.


  • Ticker MRK
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,533,280,000
  • Market Cap $257B
  • Description
  • Merck & Co., Inc. operates as a healthcare company worldwide. It operates through two segments, Pharmaceutical and Animal Health. The Pharmaceutical segment offers human health pharmaceutical products in the areas of oncology, hospital acute care, immunology, neuroscience, virology, cardiovascular, and diabetes, as well as vaccine products, ...
More about MRK
Track This Portfolio

Track Capital Investment Counsel, LLC Portfolio

Follow Capital Investment Counsel, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Capital Investment Counsel, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Capital Investment Counsel, LLC with notifications on news.